ALICIA LEE: Open Payments
NPI 1891449625 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 41 payments from 14 companies in 2025. Trend: 2023 $627 · 2024 $971 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $195 |
| SCPHARMACEUTICALS INC. | 5 | $97 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $67 |
| Boston Scientific Corporation | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: LEQVIO, FUROSCIX, LifeVest, WATCHMAN Access System, NEXLETOL, Kerendia, REPATHA, ENTRESTO.
Industry payments across MO — which companies pay providers there.
